Valuation: iCAD Inc

Market Cap 106M 91.79M 85.44M 78.44M 148M 10.08B 150M 1.01B 395M 5.02B 397M 388M 16.83B P/E 2023
-9.35x
P/E 2024 -8.59x
Enterprise Value 88.75M 77.15M 71.81M 65.93M 125M 8.47B 126M 846M 332M 4.22B 333M 326M 14.14B EV / Sales 2023
1.47x
EV / Sales 2024 1.6x
Free-Float
99.32%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 61 10/03/2023
Director of Finance/CFO 54 17/07/2025
Corporate Secretary - 17/07/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%+1.06%+22.80%+4.67% 213B
-0.61%+1.82%-1.11%-23.56% 137B
+0.10%+4.69%-26.56%+8.92% 125B
+1.59%+5.60%-55.46%-9.87% 69.46B
-0.98%+4.16%+8.52%+4.87% 49.56B
-0.91%+5.13%-22.07%-30.22% 47.2B
-0.25%-0.14%+20.52%+13.63% 39.08B
-0.79%+0.70%+30.67%+36.60% 37.05B
-2.75%+12.28%-4.63%-12.79% 30.72B
Average -0.56%+3.87%-3.03%-0.86% 83.15B
Weighted average by Cap. -0.36%+3.04%-1.71%-1.99%

Financials

2023 2024
Net sales 17.32M 15.05M 14.01M 12.87M 24.29M 1.65B 24.67M 165M 64.82M 823M 65.04M 63.61M 2.76B 19.61M 17.05M 15.87M 14.57M 27.51M 1.87B 27.93M 187M 73.4M 932M 73.64M 72.02M 3.12B
Net income -4.85M -4.21M -3.92M -3.6M -6.8M -463M -6.91M -46.23M -18.14M -230M -18.2M -17.8M -772M -5.62M -4.88M -4.54M -4.17M -7.88M -536M -8M -53.56M -21.02M -267M -21.09M -20.63M -895M
Net Debt -21.21M -18.44M -17.16M -15.76M -29.75M -2.02B -30.21M -202M -79.39M -1.01B -79.65M -77.9M -3.38B -16.84M -14.64M -13.63M -12.51M -23.63M -1.61B -24M -161M -63.05M -801M -63.26M -61.87M -2.68B
Logo iCAD Inc
iCAD Inc is a United States‑based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AI‑driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.
Employees
-